The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTanfield Regulatory News (TAN)

Share Price Information for Tanfield (TAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.70
Bid: 3.72
Ask: 4.10
Change: 0.01 (0.26%)
Spread: 0.38 (10.215%)
Open: 3.70
High: 3.70
Low: 3.70
Prev. Close: 3.90
TAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Snorkel Investment & Legal Proceeding Update

18 Oct 2022 10:48

RNS Number : 2714D
Tanfield Group PLC
18 October 2022
 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

Tanfield Group Plc

("Tanfield" or the "Company")

 

Snorkel Investment & Legal Proceeding Update

 

 

The Board of Tanfield (the "Board") is pleased to update the market regarding the Company's ongoing legal proceedings in relation to its investment in Snorkel International Holdings LLC ("Snorkel"), the aerial work platform business.

 

 

Investment Background

 

· Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme Manufacturing LLC ("Xtreme") (the "Contemplated Transaction"), a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

· The Snorkel investment is valued at £19.1m. The outcome of the US and UK Proceedings referenced below could have an impact on this valuation.

 

· On 22 October 2019, the Company announced that it had received a Summons and Complaint, filed in Nevada (the "US Proceedings") by subsidiaries of Xtreme, relating to the Contemplated Transaction.

 

· On 24 October 2019, the Company announced it had become necessary to issue and serve a claim in the English High Court against Ward Hadaway (the "UK Proceedings"), the solicitor acting for the Company at the time of the Contemplated Transaction, in order to fully protect the Company's rights. 

 

· On 26 February 2021, Ward Hadaway was granted permission to join Foulston Siefkin, Tanfield's US based law firm who were retained in 2013 to draft the documents governed by US law relating to the Contemplated Transaction, into the UK Proceedings. As a result, the Company amended its claim to include Foulston Siefkin as a second defendant.

 

· On 14 October 2022, the Company announced that it had agreed to settle its claim against Foulston Siefkin in relation to the UK Proceedings on a no-fault basis for the sum of $4.5m (£4.0m).

 

 

Highlights

 

· The Company has agreed to settle its claim against Ward Hadaway in relation to the UK Proceedings on a no-fault basis for the sum of £2.9m including interest and costs.

 

· This brings an end to the UK Proceedings and, once the agreed Court Order is approved, the 3-week trial scheduled to begin on 7 November 2022 will be vacated. 

 

· The Company will now focus entirely on the US Proceedings, which are continuing and the jury trial is currently expected to take place around the summer of 2023. 

 

 

Business Update

 

Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme, a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

Non-Fault Settlement

 

Following the announcement on 14 October 2022, in which the Company announced that it had agreed to settle its claim against Foulston Siefkin in relation to the UK Proceedings on a no-fault basis for the sum of $4.5m (£4.0m), the Board is pleased to announce that the Company has now also reached an agreement to settle its claim against Ward Hadaway, the solicitor acting for the Company at the time of the Contemplated Transaction, on a no-fault basis for the sum of £2.9m including interest and costs. For the avoidance of doubt, the agreed settlement should not be construed as an admission of liability or wrongdoing by Ward Hadaway. Save as required under the AIM Rules for Companies, to which the Company remains subject, the terms of the settlement remain confidential between the parties.

 

UK & US Legal Proceedings

 

As a result of reaching no-fault settlements with both parties in relation to the UK Proceedings, amounting to £6.9m collectively, the 3-week trial scheduled to begin on 7 November 2022 will now be vacated, bringing an end to the UK Proceedings

 

As reported in the Company's 2021 Report and Financial Statements, £1.25m of cash is held on deposit with the English Court as security in relation to the UK Proceedings. As a result of reaching no-fault settlements with both parties, bringing an end to the UK Proceedings, the £1.25m of security will also be released and returned to the Company.

 

As updated on 14 October 2022, the US Proceedings are continuing and the Company will now focus entirely on those proceedings. Whilst there are ongoing deficiencies in the production of documents by Snorkel / Xtreme, the jury trial is currently still expected to take place around the summer of 2023.

 

The Board continues to believe that a positive outcome to the US Proceedings is possible. So far as it is necessary, the Company will continue to vigorously defend its position, whilst continuing to seek advice.

 

Use of Funds

 

As updated on 14 October 2022, following the no-fault settlement with Foulston Siefkin, any excess funds would be used to repay a proportion of the Company's loan note instruments. As a consequence of the further above settlement with Ward Hadaway, the Company will now, as required by the loan agreements, seek to fully repay its £2.825m of loans, plus accrued interest and early redemption premiums. The remaining funds will be used to provide ongoing working capital funding, including costs related to the US Proceedings.

 

The Board believes that it has the necessary funding to ensure that the Company can continue to protect its investment in Snorkel. 

 

Further updates will be provided to Shareholders as and when appropriate.

 

 

 

For further information:

 

Tanfield Group Plc 020 7220 1666

Daryn Robinson

 

WH Ireland Limited - Nominated Advisor / Broker

James Joyce / Megan Liddell 020 7220 1666

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBKFBQCBDKOKD
Date   Source Headline
25th Apr 20249:14 amRNSReplacement Final Results for year end 31 Dec 2023
25th Apr 20247:00 amRNSFinal Results for the year ended 31 Dec 2023
20th Nov 20231:01 pmRNSSnorkel Investment Update
17th Aug 20237:00 amRNSSnorkel Investment Update
24th Jul 20237:00 amRNSInterim Results for the six-months to 30 June 2023
2nd Jun 20237:00 amRNSResult of AGM
18th May 20237:00 amRNSSnorkel Investment Update
21st Apr 20237:00 amRNSFinal Results and Notice of AGM
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSSnorkel Investment Update
15th Nov 20229:54 amRNSSnorkel Investment Update
18th Oct 20224:40 pmRNSSecond Price Monitoring Extn
18th Oct 20224:35 pmRNSPrice Monitoring Extension
18th Oct 202210:48 amRNSSnorkel Investment & Legal Proceeding Update
14th Oct 20221:17 pmRNSSnorkel Investment & Legal Proceeding Update
9th Sep 20227:00 amRNSInterim Results for the six months to 30 June 2022
24th Aug 20227:00 amRNSSnorkel Investment & Loan Subscription Update
3rd Aug 20228:46 amRNSResult of AGM
19th Jul 20224:36 pmRNSPrice Monitoring Extension
30th Jun 20227:00 amRNSFinal Results and Notice of AGM
26th May 202211:44 amRNSSnorkel Investment Update
24th May 20227:00 amRNSLoan Note Instrument
12th May 20224:40 pmRNSSecond Price Monitoring Extn
12th May 20224:35 pmRNSPrice Monitoring Extension
10th May 20227:00 amRNSSnorkel Investment & Legal Proceedings Update
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 202212:56 pmRNSLoan Subscription Update
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
18th Feb 20224:35 pmRNSPrice Monitoring Extension
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSSnorkel Legal Proceedings Update
28th Jan 20224:41 pmRNSSecond Price Monitoring Extn
28th Jan 20224:36 pmRNSPrice Monitoring Extension
27th Jan 20224:37 pmRNSPrice Monitoring Extension
18th Jan 20224:41 pmRNSSecond Price Monitoring Extn
18th Jan 20224:35 pmRNSPrice Monitoring Extension
4th Jan 20224:41 pmRNSSecond Price Monitoring Extn
4th Jan 20224:36 pmRNSPrice Monitoring Extension
29th Dec 20214:41 pmRNSSecond Price Monitoring Extn
29th Dec 20214:35 pmRNSPrice Monitoring Extension
16th Dec 20214:42 pmRNSSecond Price Monitoring Extn
16th Dec 20214:36 pmRNSPrice Monitoring Extension
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
3rd Dec 20214:41 pmRNSSecond Price Monitoring Extn
3rd Dec 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20214:36 pmRNSPrice Monitoring Extension
22nd Nov 20214:35 pmRNSPrice Monitoring Extension
18th Nov 20217:00 amRNSSnorkel Investment Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.